Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00355589 · ClinicalTrials.gov registry record · Phase 3
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00355589: Completed Phase 3 study, sponsored by Pfizer.
NCT00355589 is a Phase 3 study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00355589, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to determine if there is greater blood pressure reduction using ramipril or hydrochlorothiazide alone or ramipril and hydrochlorothiazide together.
Interventions
- DRUG Ramipril and hydrochlorothiazide
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-07 |
| Est. Completion | 2007-03 |
| Phase | Phase 3 |
What the finished NCT00355589 record still lists
NCT00355589 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Ramipril and hydrochlorothiazide is the first listed.
NCT00355589 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00355589 about?
NCT00355589 is a clinical study titled "Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension". The purpose of this study is to determine if there is greater blood pressure reduction using ramipril or hydrochlorothiazide alone or ramipril and hydrochlorothiazide together.
What is the current status of trial NCT00355589?
This trial is currently completed. It is a Phase 3 study. The study started on 2006-07. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00355589?
The interventions under investigation include: Ramipril and hydrochlorothiazide (DRUG).
Who is sponsoring clinical trial NCT00355589?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia